Novan, Inc. (NOVN) financial statements (2022 and earlier)

Company profile

Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110
DURHAM, NC 27703
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments47,08535,87913,7118,1942,52434,611
Cash and cash equivalents47,08535,87913,7118,1942,52434,611
Prepaid expense1,6971,818    
Deferred costs 584949297 
Disposal group, including discontinued operation 114    
Other undisclosed current assets5,3486,1381,9641,107883958
Total current assets:54,13044,00715,7249,3503,70435,569
Noncurrent Assets
Operating lease, right-of-use asset1,693 1,833
Property, plant and equipment12,2012,40610,50615,86816,62416,290
Intangible assets, net (including goodwill)757575757575
Intangible assets, net (excluding goodwill)757575757575
Restricted cash and investments583 540539539539
Other noncurrent assets278341419530192 
Total noncurrent assets:14,8302,82213,37317,01217,43016,904
TOTAL ASSETS:68,96046,82929,09726,36221,13452,473
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,9643,3153,2084,0864,8517,630
Accounts payable2,1701,1921,6021,2504793,130
Accrued liabilities3,2519691,1691,3692,2042,195
Employee-related liabilities1,5431,1544371,4672,1682,305
Deferred revenue2,5862,9904,428
Debt 4781,162111110
Deferred revenue and credits2,164 
Contract with customer, liability4,401
Other undisclosed current liabilities1,6001,9174,1015631,3925,737
Total current liabilities:11,1508,70012,8999,0618,41813,377
Noncurrent Liabilities
Long-term debt and lease obligation3,6134785,100102132
Long-term debt, excluding current maturities 478    
Capital lease obligations102132
Operating lease, liability3,613 5,100
Liabilities, other than long-term debt10,7369,0257,6544,0956,919 
Deferred revenue and credits6,919 
Deferred revenue10,6658,2387,076
Contract with customer, liability2,566
Other liabilities71787578289  
Derivative instruments and hedges, liabilities   1,240  
Other undisclosed noncurrent liabilities25,14225,64925,7277,9987,9987,998
Total noncurrent liabilities:39,49135,15238,48112,10314,9388,030
Total liabilities:50,64143,85251,38021,16423,35621,407
Stockholders' equity
Stockholders' equity attributable to parent18,3192,977(22,283)5,198(2,222)31,066
Common stock2143322
Treasury stock, value(155)(155)(155)(155)(155)(155)
Additional paid in capital297,441252,395197,853177,677158,091154,252
Accumulated deficit(278,969)(249,277)(219,984)(172,327)(160,160)(123,033)
Total stockholders' equity:18,3192,977(22,283)5,198(2,222)31,066
TOTAL LIABILITIES AND EQUITY:68,96046,82929,09726,36221,13452,473

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues2,9584,9204,8965,9912,140 
Gross profit:2,9584,9204,8965,9912,140 
Operating expenses(32,873)(35,134)(35,584)(34,552)(38,325)(59,826)
Operating loss:(29,915)(30,214)(30,688)(28,561)(36,185)(59,826)
Nonoperating income (expense)22392131115,888(942)127
Investment income, nonoperating     81
Other nonoperating income (expense)(746)87013672 48
Interest and debt expense956 (2)(1,047) (2)
Net loss:(28,736)(29,293)(30,379)(13,720)(37,127)(59,701)
Other undisclosed net income (loss) attributable to parent(956) 21,047 2
Net loss available to common stockholders, diluted:(29,692)(29,293)(30,377)(12,673)(37,127)(59,699)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(28,736)(29,293)(30,379)(13,720)(37,127)(59,701)
Comprehensive loss:(28,736)(29,293)(30,379)(13,720)(37,127)(59,701)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(956) 21,047  
Comprehensive loss, net of tax, attributable to parent:(29,692)(29,293)(30,377)(12,673)(37,127)(59,701)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: